1 Beck M, Schirmacher P, Singer S (2017) Alterations of the nuclear transport system in hepatocellular carcinoma - New basis for therapeutic strategies. Journal of hepatology 67: 1051-1061 Doi 10.1016/j.jhep.2017.06.021
2 Bi J, Chowdhry S, Wu S, Zhang W, Masui K, Mischel PS (2020) Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets. Nature reviews Cancer 20: 57-70 Doi 10.1038/s41568-019-0226-5
3 Cagatay T, Chook YM (2018) Karyopherins in cancer. Current opinion in cell biology 52: 30-42 Doi 10.1016/j.ceb.2018.01.006
4 Cancer Genome Atlas Research N, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci Met al (2015) Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. The New England journal of medicine 372: 2481-2498 Doi 10.1056/NEJMoa1402121
5 Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DEet al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555: 469-474 Doi 10.1038/nature26000
6 Cardoso F, van't Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, Pierga JY, Brain E, Causeret S, DeLorenzi Met al (2016) 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. The New England journal of medicine 375: 717-729 Doi 10.1056/NEJMoa1602253
7 Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, Morozova O, Newton Y, Radenbaugh A, Pagnotta SMet al (2016) Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell 164: 550-563 Doi 10.1016/j.cell.2015.12.028
8 Chari A, Vogl DT, Gavriatopoulou M, Nooka AK, Yee AJ, Huff CA, Moreau P, Dingli D, Cole C, Lonial Set al (2019) Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma. The New England journal of medicine 381: 727-738 Doi 10.1056/NEJMoa1903455
9 Chen L, Cao MF, Zhang X, Dang WQ, Xiao JF, Liu Q, Tan YH, Tan YY, Xu YY, Xu SLet al (2019) The landscape of immune microenvironment in lung adenocarcinoma and squamous cell carcinoma based on PD-L1 expression and tumor-infiltrating lymphocytes. Cancer medicine 8: 7207-7218 Doi 10.1002/cam4.2580
10 Cristescu R, Mogg R, Ayers M, Albright A, Murphy E, Yearley J, Sher X, Liu XQ, Lu H, Nebozhyn Met al (2018) Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science 362: Doi 10.1126/science.aar3593
11 Hu H, Mu Q, Bao Z, Chen Y, Liu Y, Chen J, Wang K, Wang Z, Nam Y, Jiang Bet al (2018) Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor. Cell 175: 1665-1678 e1618 Doi 10.1016/j.cell.2018.09.038
12 Kau TR, Way JC, Silver PA (2004) Nuclear transport and cancer: from mechanism to intervention. Nature reviews Cancer 4: 106-117 Doi 10.1038/nrc1274
13 Kim J, McMillan E, Kim HS, Venkateswaran N, Makkar G, Rodriguez-Canales J, Villalobos P, Neggers JE, Mendiratta S, Wei Set al (2016) XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer. Nature 538: 114-117 Doi 10.1038/nature19771
14 Li J, Liu Q, Liu Z, Xia Q, Zhang Z, Zhang R, Gao T, Gu G, Wang Y, Wang Det al (2018) KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc. Journal of experimental & clinical cancer research : CR 37: 194 Doi 10.1186/s13046-018-0861-9
15 Liu J, Lu H, Ohgaki H, Merlo A, Shen Z (2009) Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas. BMC cancer 9: 268 Doi 10.1186/1471-2407-9-268
16 Liu XL, Zhao D, Sun DP, Wang Y, Li Y, Qiu FQ, Ma P (2012) Adenovirus-mediated delivery of CALR and MAGE-A3 inhibits invasion and angiogenesis of glioblastoma cell line U87. Journal of experimental & clinical cancer research : CR 31: 8 Doi 10.1186/1756-9966-31-8
17 Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta neuropathologica 131: 803-820 Doi 10.1007/s00401-016-1545-1
18 Lu CF, Hsu FT, Hsieh KL, Kao YJ, Cheng SJ, Hsu JB, Tsai PH, Chen RJ, Huang CC, Yen Yet al (2018) Machine Learning-Based Radiomics for Molecular Subtyping of Gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research 24: 4429-4436 Doi 10.1158/1078-0432.CCR-17-3445
19 Mahipal A, Malafa M (2016) Importins and exportins as therapeutic targets in cancer. Pharmacology & therapeutics 164: 135-143 Doi 10.1016/j.pharmthera.2016.03.020
20 Merico D, Isserlin R, Stueker O, Emili A, Bader GD (2010) Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PloS one 5: e13984 Doi 10.1371/journal.pone.0013984
21 Mobadersany P, Yousefi S, Amgad M, Gutman DA, Barnholtz-Sloan JS, Velazquez Vega JE, Brat DJ, Cooper LAD (2018) Predicting cancer outcomes from histology and genomics using convolutional networks. Proceedings of the National Academy of Sciences of the United States of America 115: E2970-E2979 Doi 10.1073/pnas.1717139115
22 Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park Tet al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. The New England journal of medicine 351: 2817-2826 Doi 10.1056/NEJMoa041588
23 Rodriguez-Bravo V, Pippa R, Song WM, Carceles-Cordon M, Dominguez-Andres A, Fujiwara N, Woo J, Koh AP, Ertel A, Lokareddy RKet al (2018) Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import. Cell 174: 1200-1215 e1220 Doi 10.1016/j.cell.2018.07.015
24 Shigeyasu K, Okugawa Y, Toden S, Boland CR, Goel A (2017) Exportin-5 Functions as an Oncogene and a Potential Therapeutic Target in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 23: 1312-1322 Doi 10.1158/1078-0432.CCR-16-1023
25 Stewart M (2007) Molecular mechanism of the nuclear protein import cycle. Nature reviews Molecular cell biology 8: 195-208 Doi 10.1038/nrm2114
26 Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ESet al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102: 15545-15550 Doi 10.1073/pnas.0506580102
27 Tan MSY, Sandanaraj E, Chong YK, Lim SW, Koh LWH, Ng WH, Tan NS, Tan P, Ang BT, Tang C (2019) A STAT3-based gene signature stratifies glioma patients for targeted therapy. Nature communications 10: 3601 Doi 10.1038/s41467-019-11614-x
28 Wu F, Zhao Z, Chai RC, Liu YQ, Li GZ, Jiang HY, Jiang T (2019) Prognostic power of a lipid metabolism gene panel for diffuse gliomas. Journal of cellular and molecular medicine 23: 7741-7748 Doi 10.1111/jcmm.14647
29 Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. Omics : a journal of integrative biology 16: 284-287 Doi 10.1089/omi.2011.0118
30 Zhang GH, Zhong QY, Gou XX, Fan EX, Shuai Y, Wu MN, Yue GJ (2019) Seven genes for the prognostic prediction in patients with glioma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21: 1327-1335 Doi 10.1007/s12094-019-02057-3
31 Zuo S, Zhang X, Wang L (2019) A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma. Scientific reports 9: 2615 Doi 10.1038/s41598-019-39273-4